Who founded Rosebud Biosciences?

Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall in 2020.

Who are Rosebud Biosciences's investors?

Rosebud Biosciences's investors include Pioneer, Y Combinator, 10X Capital, Asymmetry Ventures, FAST — by GETTYLAB, Incite.org.

Where is Rosebud Biosciences headquartered?

Rosebud Biosciences is headquartered in San Francisco, US.

Rosebud Biosciences

YC W22

San Francisco, US · Founded 2020 · 3 employees · 6 known investors

Find your way into Rosebud Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Rosebud Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.

Also known as Rosebud Biosciences Inc.

Biotech Deep Tech Healthtech Medical Devices AI-powered Drug Discovery PediatricsUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (W22)

Rosebud Biosciences was founded in 2020 by Kitch Wilson and Evan Lyall.

Kitch Wilson Co-founder and CEOKitch Wilson is a physician and molecular biologist with over 15 years of experience in induced pluripotent stem cell research and genomic technologies. He completed medical and doctoral training at Stanford, where he spent six years as an attending physician before co-founding Rosebud Biosciences.

Evan Lyall Co-founder and CTOHe holds a PhD and has spent a decade in advanced microscopy, machine learning, and data engineering, including research at UC Berkeley on neural coding and brain-machine interfaces, followed by contract data and ML engineering roles at early-stage companies.

Investors · 6

Pioneerlisted by PioneerToronto, Ontario

How we know: Y Combinator's founder network · pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

10X CapitalreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Asymmetry VenturesreportedRichmond · $125K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

FAST — by GETTYLABreportedSan Francisco · $100K

How we know: Y Combinator's founder network · Not right? Tell us

Incite.orgreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

The YC application· Winter 2022 batch

▶ Demo Day video — watch on YC ↗

What they told YC

How long have each of you been working on this? How much of that has been full-time? Please explain.: Kitch, the CEO, started working full-time on the company's business plan and platform concept in June 2020, and Evan joined full-time as cofounder and CTO in January 2021.

Summarized from the founders' answers on their Y Combinator profile.

Related companies · 5

Brave CareBrave Care operates pediatric primary and urgent care clinics designed to treat common acute conditions in children, supplemented by remote consultations delivered by clinicians. The service offers an alternative to emergency departments for conditions like infections, injuries, and fevers at lower cost and faster visits.

Blueberry PediatricsBlueberry Pediatrics provides 24/7 telemedicine consultations with board-certified pediatricians for families, supplemented by an at-home diagnostic kit to expand diagnosis capabilities and reduce urgent care visits.

Synkrino BiotherapeuticsBuilding new drugs to target inflammation using an AI + immunology discovery engine.

Diffuse BioDiffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.

Reverie LabsReverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.

Companies working in the same space as Rosebud Biosciences.

Legal entities · 1

corporate structure

Rosebud Biosciences Inc.

Frequently asked questions

What does Rosebud Biosciences do?: Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.
Who founded Rosebud Biosciences?: Rosebud Biosciences was founded by Kitch Wilson, Evan Lyall in 2020.
Who are Rosebud Biosciences's investors?: Rosebud Biosciences's investors include Pioneer, Y Combinator, 10X Capital, Asymmetry Ventures, FAST — by GETTYLAB, Incite.org.
Where is Rosebud Biosciences headquartered?: Rosebud Biosciences is headquartered in San Francisco, US.